Analysis

COVID-19 A data perspective

COVID-19: A data perspective: Explore key economic trends and social challenges that arise as the COVID-19 situation evolves.

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Year of publication

1 facets displayed. 0 facets selected.

Author(s)

1 facets displayed. 0 facets selected.

Survey or statistical program

2 facets displayed. 2 facets selected.
Sort Help
entries

Results

All (1)

All (1) ((1 result))

  • Articles and reports: 88-003-X20030026570
    Geography: Canada
    Description:

    In 2001, Canadian biotech firms raised $980 million in financing capital, a sharp drop from the $2.1 billion raised in 1999. Overall, 114 firms out of 188 (61%) that attempted to raise capital either failed or did not reach their targets. Why are biotech firms encountering difficulties in raising financing capital?

    Release date: 2003-06-27
Stats in brief (0)

Stats in brief (0) (0 results)

No content available at this time.

Articles and reports (1)

Articles and reports (1) ((1 result))

  • Articles and reports: 88-003-X20030026570
    Geography: Canada
    Description:

    In 2001, Canadian biotech firms raised $980 million in financing capital, a sharp drop from the $2.1 billion raised in 1999. Overall, 114 firms out of 188 (61%) that attempted to raise capital either failed or did not reach their targets. Why are biotech firms encountering difficulties in raising financing capital?

    Release date: 2003-06-27
Journals and periodicals (0)

Journals and periodicals (0) (0 results)

No content available at this time.

Date modified: